329 related articles for article (PubMed ID: 17937777)
1. A template-assembled model of the N-peptide helix bundle from HIV-1 Gp-41 with high affinity for C-peptide.
Xu W; Taylor JW
Chem Biol Drug Des; 2007 Oct; 70(4):319-28. PubMed ID: 17937777
[TBL] [Abstract][Full Text] [Related]
2. The hydrophobic pocket contributes to the structural stability of the N-terminal coiled coil of HIV gp41 but is not required for six-helix bundle formation.
Dwyer JJ; Hasan A; Wilson KL; White JM; Matthews TJ; Delmedico MK
Biochemistry; 2003 May; 42(17):4945-53. PubMed ID: 12718536
[TBL] [Abstract][Full Text] [Related]
3. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
4. Chemoenzymatic synthesis of HIV-1 gp41 glycopeptides: effects of glycosylation on the anti-HIV activity and alpha-helix bundle-forming ability of peptide C34.
Wang LX; Song H; Liu S; Lu H; Jiang S; Ni J; Li H
Chembiochem; 2005 Jun; 6(6):1068-74. PubMed ID: 15883971
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamics of trimer-of-hairpins formation by the SIV gp41 envelope protein.
Jelesarov I; Lu M
J Mol Biol; 2001 Mar; 307(2):637-56. PubMed ID: 11254387
[TBL] [Abstract][Full Text] [Related]
6. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
Joshi SB; Dutch RE; Lamb RA
Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
[TBL] [Abstract][Full Text] [Related]
7. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.
Korazim O; Sackett K; Shai Y
J Mol Biol; 2006 Dec; 364(5):1103-17. PubMed ID: 17045292
[TBL] [Abstract][Full Text] [Related]
8. Conformational study of fragments of envelope proteins (gp120: 254-274 and gp41: 519-541) of HIV-1 by NMR and MD simulations.
Kanyalkar M; Srivastava S; Saran A; Coutinho E
J Pept Sci; 2004 Jun; 10(6):363-80. PubMed ID: 15214441
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120.
Desmezieres E; Gupta N; Vassell R; He Y; Peden K; Sirota L; Yang Z; Wingfield P; Weiss CD
J Virol; 2005 Apr; 79(8):4774-81. PubMed ID: 15795263
[TBL] [Abstract][Full Text] [Related]
10. Expression and biochemical analysis of the entire HIV-2 gp41 ectodomain: determinants of stability map to N- and C-terminal sequences outside the 6-helix bundle core.
Lay CS; Wilson KA; Kobe B; Kemp BE; Drummer HE; Poumbourios P
FEBS Lett; 2004 Jun; 567(2-3):183-8. PubMed ID: 15178320
[TBL] [Abstract][Full Text] [Related]
11. The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.
Louis JM; Baber JL; Clore GM
Biochemistry; 2015 Nov; 54(45):6796-805. PubMed ID: 26506247
[TBL] [Abstract][Full Text] [Related]
12. Development of a FRET assay for monitoring of HIV gp41 core disruption.
Xu Y; Hixon MS; Dawson PE; Janda KD
J Org Chem; 2007 Aug; 72(18):6700-7. PubMed ID: 17685571
[TBL] [Abstract][Full Text] [Related]
13. Conformational stability and membrane interaction of the full-length ectodomain of HIV-1 gp41: implication for mode of action.
Lev N; Fridmann-Sirkis Y; Blank L; Bitler A; Epand RF; Epand RM; Shai Y
Biochemistry; 2009 Apr; 48(14):3166-75. PubMed ID: 19206186
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes.
Moreno MR; Guillén J; Pérez-Berna AJ; Amorós D; Gómez AI; Bernabeu A; Villalaín J
Biochemistry; 2007 Sep; 46(37):10572-84. PubMed ID: 17711304
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
16. Calmodulin binding properties of peptide analogues and fragments of the calmodulin-binding domain of simian immunodeficiency virus transmembrane glycoprotein 41.
Yuan T; Tencza S; Mietzner TA; Montelaro RC; Vogel HJ
Biopolymers; 2001 Jan; 58(1):50-62. PubMed ID: 11072229
[TBL] [Abstract][Full Text] [Related]
17. Coiled-coil surface presentation: an efficient HIV gp41 binding interface mimic.
Schnarr NA; Kennan AJ
J Am Chem Soc; 2004 Aug; 126(33):10260-1. PubMed ID: 15315435
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 gp41 tertiary structure studied by EPR spectroscopy.
Rabenstein MD; Shin YK
Biochemistry; 1996 Nov; 35(44):13922-8. PubMed ID: 8909289
[TBL] [Abstract][Full Text] [Related]
19. High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.
Jin BS; Lee WK; Ahn K; Lee MK; Yu YG
J Biomol Screen; 2005 Feb; 10(1):13-9. PubMed ID: 15695339
[TBL] [Abstract][Full Text] [Related]
20. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]